References
- D.G. Altman and C.J. Doré, Randomization and baseline comparison in clinical trials, Lancet 335 (1990), pp. 149–153. doi: 10.1016/0140-6736(90)90014-V
- N.E. Breslow, Contribution to the discussion on the paper by DR Cox, regression and life tables, J. R. Stat. Soc. Ser. B Stat. Methodol. 34 (1972), pp. 216–217.
- G.M. Callagy, M.J. Webber, P.D.F. Pharoah, and C. Caldas, Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer, BMC Cancer 8 (2008), pp. 153. doi: 10.1186/1471-2407-8-153
- Colorectal Cancer Collaborative Group, Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomised trials, Lancet 358 (2001), pp. 1291–1304. doi: 10.1016/S0140-6736(01)06409-1
- D.R. Cox, Regression models and life tables (with discussion), J. R. Stat. Soc. Ser. B Stat. Methodol. 34 (1972), pp. 187–220.
- R. DerSimonian and R. Kacker, Random-effects model for meta-analysis of clinical trials: An update, Contemp. Clin. Trials 28 (2006), pp. 105–114. doi: 10.1016/j.cct.2006.04.004
- M. Dowsett, J. Cuzick, C. Wale, J. Forbes, E.A. Mallon, J. Salter, E. Quinn, A. Dunbier, M. Baum, A. Buzdat, A. Howell, R. Bugarini, R. Baehner, and S. Shak, Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: A TransATAC study, J. Clin. Oncol. 28 (2010), pp. 1829–1834. 10.1200/JCO.2009.24.4798
- Early Breast Cancer Trialists’ Collaborative Group, Polychemotherapy for early breast cancer: An overview of the randomised trials, Lancet 352 (1998), pp. 930–942. doi: 10.1016/S0140-6736(98)03301-7
- R.A. Fisher, Statistical Methods for Research Workers, Oliver and Boyd, London, 1925.
- L.V. Hedges and J.L. Vevea, Fixed- and random-effects models in meta-analysis, Psychol. Methods 3 (1998), pp. 486–504. doi: 10.1037/1082-989X.3.4.486
- S. Paik, S. Shak, G. Tang, C. Kim, J. Baker, M. Cronin, F. Baehner, M.G. Walker, D. Watson, T. Park, W. Hiller, E.R. Fisher, D.L. Wickerham, J. Bryant, and N. Wolmark, A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer, N. Engl. J. Med. 351 (2004), pp. 2817–2826. doi: 10.1056/NEJMoa041588
- R.C. Paule and J. Mandel, Consensus values and weighting factors, J. Res. Natl. Bur. Stand. 87 (1982), pp. 377–385. doi: 10.6028/jres.087.022
- E. Roecker, Prediction error and its estimation for subset-selected models, Technometrics 33 (1991), pp. 459–468. doi: 10.1080/00401706.1991.10484873
- P. Royston and M.K.B. Parmar, Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modeling and estimation of treatment effects, Stat. Med. 21 (2002), pp. 2175–2197. doi: 10.1002/sim.1203
- A.L. Rukhin, B.J. Biggerstaff, and M.G. Vangel, Restricted maximum likelihood estimation of a common mean and the Mandel–Paule algorithm, J. Stat. Plan. Inference 83 (2000), pp. 319–330. doi: 10.1016/S0378-3758(99)00098-1
- G. Tang, J. Cuzick, J.P. Costantino, M. Dowsett, J.F. Forbes, M. Crager, E.P. Mamounas, S. Shak, and N. Wolmark, Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: Recurrence score alone and integrated with pathologic and clinical factors, J. Clin. Oncol. 29 (2011), pp. 4365–4372. 10.1200/JCO.2011.35.3714
- T.M. Therneau and P.M. Grambsch, Modeling Survival Data: Extending the Cox Model, Springer, New York, 2000.
- A. Tsiatis, A large sample study of the estimates for the integrated hazard function in Cox's regression model for survival data, Ann. Stat. 9 (1981), pp. 93–108. doi: 10.1214/aos/1176345335
- L. Warnock, R. Stephens, and J. Coleman, Methods of Microarray Data Analysis IV. Springer, New York, 2006.